Corcept Therapeutics, Inc. (CORT)
116.23
+2.20
(+1.93%)
USD |
NASDAQ |
Oct 02, 16:00
116.23
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Price : 116.23 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 114.38 | 117.32 | 113.90 | 116.23 | 960162.0 |
| Oct 01, 2026 | 114.29 | 115.98 | 111.94 | 114.02 | 878988.0 |
| Sep 30, 2026 | 114.80 | 118.07 | 113.98 | 115.23 | 910311.0 |
| Sep 29, 2026 | 115.92 | 120.51 | 113.16 | 114.74 | 964470.0 |
| Sep 28, 2026 | 116.00 | 117.07 | 114.36 | 115.63 | 1.155M |
| Sep 25, 2026 | 119.00 | 120.44 | 114.51 | 116.10 | 800797.0 |
| Sep 24, 2026 | 111.86 | 119.15 | 111.68 | 118.51 | 983632.0 |
| Sep 23, 2026 | 117.33 | 118.79 | 112.04 | 112.94 | 809874.0 |
| Sep 22, 2026 | 113.96 | 119.00 | 113.09 | 117.50 | 810250.0 |
| Sep 21, 2026 | 110.29 | 116.65 | 109.00 | 113.76 | 1.347M |
| Sep 18, 2026 | 116.80 | 117.90 | 108.41 | 110.29 | 17.23M |
| Sep 17, 2026 | 113.18 | 115.09 | 111.07 | 114.86 | 883644.0 |
| Sep 16, 2026 | 110.82 | 113.60 | 110.49 | 111.81 | 668643.0 |
| Sep 15, 2026 | 111.97 | 112.80 | 109.40 | 110.82 | 1.459M |
| Sep 14, 2026 | 113.38 | 114.52 | 111.10 | 111.80 | 1.231M |
| Sep 11, 2026 | 115.22 | 117.84 | 109.30 | 112.79 | 1.282M |
| Sep 10, 2026 | 114.42 | 116.99 | 113.20 | 114.92 | 683008.0 |
| Sep 09, 2026 | 114.20 | 117.50 | 113.77 | 115.70 | 572049.0 |
| Sep 08, 2026 | 108.87 | 115.28 | 108.25 | 113.98 | 1.046M |
| Sep 04, 2026 | 110.59 | 112.13 | 109.26 | 111.62 | 604557.0 |
| Sep 03, 2026 | 110.38 | 114.61 | 109.43 | 112.80 | 611215.0 |
| Sep 02, 2026 | 113.38 | 115.78 | 108.72 | 110.43 | 960830.0 |
| Sep 01, 2026 | 113.92 | 115.85 | 111.13 | 113.38 | 1.112M |
| Aug 31, 2026 | 113.64 | 114.52 | 111.23 | 113.35 | 636565.0 |
| Aug 28, 2026 | 117.14 | 118.67 | 112.97 | 113.88 | 917931.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1142.85 |
| Pfizer Inc. | 27.80 |
| Aclaris Therapeutics, Inc. | 4.39 |
| Bristol Myers Squibb Co. | 61.15 |
| Liquidia Corp. | 28.64 |
Price Related Metrics
| PE Ratio | 277.60 |
| PS Ratio | 16.16 |
| Price to Book Value | 17.77 |
| Price to Free Cash Flow | 125.59 |
| Earnings Yield | 0.36% |
| Market Cap | 12.54B |
| Operating PE Ratio | 2096.47 |
| Normalized PE Ratio | 277.60 |